Post

A
Reposted

Polpharma S.A. (Starogard Gdański, Polska). 2024 revenue ~PLN3.5Mld. Largest Polish pharma. Cardiology, gastroenterology, CNS. Apo-Cardio, Polocard. API manufacturing. 7.5K employees.

The exposure margins are sufficient for the proposed clinical dose.

8:56:27 PM · Jul 9, 2026
Sign in to reply and join the conversation.